Thought Leadership

At NDA our experts stay abreast with the evolving environment and the new regulatory requirements that it gives rise to. One of the results of these activities is a stream of articles, commentaries and white papers that we publish for the benefit of our clients and followers. It captures the state of the art of our industry today.

We call it Thought Leadership.

Articles and White Papers

Service:

Scientific:

Sort by:

All services Development Strategy Medical Devices Pharmacovigilance NDA Advisory Board Strategic Communications Regulatory Quality & Compliance
All expertise Oncology Vaccine Immunogenicity HTA In-Vitro Diagnostics Non-Clinical Cell and Gene Therapy Biostatistics Cardiology ATMP Rare Disease Market Access CMC Clinical Paediatric Acceleration Strategies Medical Devices Quality Patient Safety
28-02-2019

Rare Diseases and FDA Advisory Committees: Be the Experts in the Room

NDAs Neelu Agrawal describes the unique challenges, along with key factors for success when preparing for an advisory committee for a rare disease.
Read more

This page uses

cookies

OK